Pediatric Behavioral Health Medication Initiative (PBHMI) Information

The MassHealth Pharmacy Program created the Pediatric Behavioral Health Medication Initiative to ensure safe and effective prescribing of behavioral health medications for members covered by MassHealth who are less than 18 years of age. Please see the links below for detailed information regarding this initiative.

PBHMI Letter to Prescribers

This letter to prescribers describes the PBHMI and goals of the initiative.

Additional Resources

Pediatric Behavioral Health Medication (PBHMI) Letter_November 2014

Pediatric Behavioral Health Medication (PBHMI) Letter_November 2014

PBHMI Clinical Document

This PBHMI clinical document provides a general overview of the initiative and the affected medication classes.

Additional Resources

PBHMI Clinical Document

PBHMI Clinical Document

PBHMI Therapeutic Class Table

This therapeutic class table displays the medications affected by the PBHMI and the MassHealth requirements for prior authorization.

Additional Resources

Table 71: Pediatric Behavioral Health

PBHMI Prior Authorization (PA) Form for Pharmacy Services

The PBHMI PA form was created to assist prescribers with requests submitted to the MassHealth Drug Utilization Review (DUR) Program.

There is also a sample Psychotropic Medication Informed Consent Form for your reference. 

See "Additional Resources," below. 

Additional Resources

PBHMI Prior Authorization (PA) Form for Pharmacy Services

PBHMI Prior Authorization (PA) Form for Pharmacy Services

Sample Psychotropic Medication Informed Consent Form

Sample Psychotropic Medication Informed Consent Form

PBHMI Q&A

This Q&A answers frequently asked questions regarding the PBHMI.

Additional Resources

MassHealth Pediatric Behavioral Health Medication Initiative—Questions and Answers

Contact Information

For Pharmacists and Prescribers

If you have questions about a specific patient or claim affected by the MassHealth Pediatric Behavioral Health Medication Initiative (PBHMI), please contact the Drug Utilization Review Program at [phone].

If you have comments about the PBHMI, contact the Drug Utilization Review Program at [phone] or e-mail the MassHealth Pharmacy Program at [e-mail]. Please include your name, title, phone number, and fax number.

Please note: MassHealth will not answer all emails but will use this feedback for further improvements to the Pediatric Behavioral Health Medication Initiative. This mailbox is dedicated to questions or comments about the MassHealth Pediatric Behavioral Health Medication Initiative only.

For MassHealth Members

If you have questions about the MassHealth Pediatric Behavioral Health Medication Initiative, please call MassHealth Customer Services at  [phone]; TTY: [phone].

Date published:	August 1, 2018
Last updated:	April 6, 2023